• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Controversies of the classification of TMA and the terminology of aHUS.

作者信息

Kato Hideki, Nangaku Masaomi, Okada Hirokazu, Kagami Shoji

机构信息

Division of Nephrology and Endocrinology, School of Medicine, The University of Tokyo, 7-3-1 Hongo,Bunkyo, Tokyo, 113-8655, Japan.

Department of Nephrology, Faculty of Medicine, Saitama Medical University, Iruma, Saitama, Japan.

出版信息

Clin Exp Nephrol. 2018 Aug;22(4):979-980. doi: 10.1007/s10157-017-1524-4. Epub 2017 Dec 27.

DOI:10.1007/s10157-017-1524-4
PMID:29282571
Abstract
摘要

相似文献

1
Controversies of the classification of TMA and the terminology of aHUS.血栓性微血管病（TMA）分类及非典型溶血尿毒综合征（aHUS）术语的争议。
Clin Exp Nephrol. 2018 Aug;22(4):979-980. doi: 10.1007/s10157-017-1524-4. Epub 2017 Dec 27.
2
[Atypical hemolytic uremic syndrome (aHUS): new insights into pathogenesis leading to novel therapeutic approaches].[非典型溶血性尿毒症综合征（aHUS）：对发病机制的新见解带来新型治疗方法]
Praxis (Bern 1994). 2016 Mar 30;105(7):389-96. doi: 10.1024/1661-8157/a002308.
3
Profiles of Coagulation and Fibrinolysis Activation-Associated Molecular Markers of Atypical Hemolytic Uremic Syndrome in the Acute Phase.在急性期，非典型溶血尿毒综合征相关凝血和纤溶激活分子标志物的特征。
J Atheroscler Thromb. 2020 Apr 1;27(4):353-362. doi: 10.5551/jat.49494. Epub 2019 Sep 4.
4
Severe hypertension with renal thrombotic microangiopathy: what happened to the usual suspect?严重高血压伴肾血栓性微血管病：常见的“嫌疑人”怎么了？
Kidney Int. 2017 Jun;91(6):1271-1274. doi: 10.1016/j.kint.2017.02.025.
5
Thrombotic microangiopathy: focus on atypical hemolytic uremic syndrome.血栓性微血管病：聚焦非典型溶血性尿毒症综合征
Hematol Oncol Clin North Am. 2015 Jun;29(3):541-59. doi: 10.1016/j.hoc.2015.02.002. Epub 2015 Apr 4.
6
At the Cross Section of Thrombotic Microangiopathy and Atypical Hemolytic Uremic Syndrome: A Narrative Review of Differential Diagnostics and a Problematization of Nomenclature.血栓性微血管病与非典型溶血尿毒综合征的交叉领域：鉴别诊断的叙述性综述及命名问题探讨
Ther Apher Dial. 2017 Aug;21(4):304-319. doi: 10.1111/1744-9987.12535. Epub 2017 May 16.
7
A Rare Case of Lupus Nephritis Presenting as Thrombotic Microangiopathy with Diffuse Pseudotubulization Possibly Caused by Atypical Hemolytic Uremic Syndrome.一例罕见的狼疮性肾炎表现为血栓性微血管病伴弥漫性假肾小管形成，可能由非典型溶血尿毒症综合征引起。
Intern Med. 2018 Jun 1;57(11):1617-1623. doi: 10.2169/internalmedicine.0228-17. Epub 2018 Feb 9.
8
Consensus regarding diagnosis and management of atypical hemolytic uremic syndrome.关于非典型溶血性尿毒症综合征的诊断和治疗的共识。
Korean J Intern Med. 2020 Jan;35(1):25-40. doi: 10.3904/kjim.2019.388. Epub 2020 Jan 2.
9
Isolated thrombotic microangiopathy of the small intestine in a patient with atypical hemolytic uremic syndrome - a case report.非典型溶血尿毒综合征患者孤立性小肠血栓性微血管病 - 病例报告。
BMC Nephrol. 2020 Mar 24;21(1):104. doi: 10.1186/s12882-020-01766-0.
10
Pathology Consultation on the Diagnosis and Treatment of Thrombotic Microangiopathies (TMAs).血栓性微血管病（TMAs）诊断与治疗的病理会诊
Am J Clin Pathol. 2016 Feb;145(2):158-65. doi: 10.1093/ajcp/aqv086.

引用本文的文献

1
Effectiveness and safety of ravulizumab for Japanese patients with atypical hemolytic uremic syndrome switched from eculizumab: an analysis of a post-marketing surveillance.瑞武利单抗用于从依库珠单抗转换治疗的日本非典型溶血尿毒综合征患者的有效性和安全性：一项上市后监测分析
Clin Exp Nephrol. 2025 Jun 14. doi: 10.1007/s10157-025-02689-6.
2
Thrombotic microangiopathy after kidney transplantation: Expanding etiologic and pathogenetic spectra.肾移植后的血栓性微血管病：病因和发病机制范围的扩展
World J Transplant. 2024 Mar 18;14(1):90277. doi: 10.5500/wjt.v14.i1.90277.
3
Eculizumab treatment in paediatric patients diagnosed with aHUS after haematopoietic stem cell transplantation: a HSCT-TMA case series from Japanese aHUS post-marketing surveillance.

本文引用的文献

1
Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.非典型溶血尿毒综合征与 C3 肾小球病：“改善全球肾脏病预后组织”（KDIGO）争议会议的结论。
Kidney Int. 2017 Mar;91(3):539-551. doi: 10.1016/j.kint.2016.10.005. Epub 2016 Dec 16.
2
Clinical guides for atypical hemolytic uremic syndrome in Japan.日本非典型溶血性尿毒症综合征临床指南。
Clin Exp Nephrol. 2016 Aug;20(4):536-543. doi: 10.1007/s10157-016-1276-6.
3
Diagnostic criteria for atypical hemolytic uremic syndrome proposed by the Joint Committee of the Japanese Society of Nephrology and the Japan Pediatric Society.
依库珠单抗治疗造血干细胞移植后诊断为 aHUS 的儿科患者：日本 aHUS 上市后监测的 HSCT-TMA 病例系列。
Bone Marrow Transplant. 2024 Mar;59(3):315-324. doi: 10.1038/s41409-023-02161-7. Epub 2023 Dec 15.
4
Clinical characteristics of anti-GBM disease with thrombotic microangiopathy: a case report and literature review.抗肾小球基底膜病伴血栓性微血管病的临床特征：病例报告及文献复习。
CEN Case Rep. 2024 Feb;13(1):37-44. doi: 10.1007/s13730-023-00797-4. Epub 2023 May 22.
5
-associated Thrombotic Microangiopathy in an Immunosuppressed Adult.免疫抑制成年患者相关的血栓性微血管病
Open Med (Wars). 2020 Mar 19;15:204-210. doi: 10.1515/med-2020-0030. eCollection 2020.
6
Atypical Hemolytic Uremic Syndrome With the p.Ile1157Thr C3 Mutation Successfully Treated With Plasma Exchange and Eculizumab: A Case Report.血浆置换联合依库珠单抗成功治疗伴有p.Ile1157Thr C3突变的非典型溶血尿毒综合征：一例报告
Crit Care Explor. 2019 Apr 17;1(4):e0008. doi: 10.1097/CCE.0000000000000008. eCollection 2019 Apr.
7
Optimal duration of treatment with eculizumab in atypical hemolytic uremic syndrome (aHUS)-a question to be addressed in a scientific way.依库珠单抗治疗非典型溶血性尿毒症综合征（aHUS）的最佳疗程——一个有待以科学方式解决的问题。
Pediatr Nephrol. 2019 May;34(5):943-949. doi: 10.1007/s00467-019-4192-7. Epub 2019 Jan 28.
日本肾脏病学会和日本儿科学会联合委员会提出的非典型溶血尿毒综合征诊断标准。
Clin Exp Nephrol. 2014 Feb;18(1):4-9. doi: 10.1007/s10157-013-0911-8.
4
Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations.补体基因突变时代的妊娠相关性溶血尿毒综合征再认识。
J Am Soc Nephrol. 2010 May;21(5):859-67. doi: 10.1681/ASN.2009070706. Epub 2010 Mar 4.